Morgan Joseph Starts Neoprobe Corp. (NEOP) at Buy; Labeling The Lymphatic System With Lymphoseek

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/17/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. HTFL
6. SNDK
7. GNK
8. WDAY
9. ADYEN:NA
10. DVLT

May 13, 2011 9:27 AM EDT
Get Alerts NEOP Hot Sheet
Price: $2.76 --0%

Rating Summary:
    2 Buy, 0 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 6 | Down: 4 | New: 7
Join SI Premium – FREE
Morgan Joseph initiates coverage on Neoprobe Corp. (NYSE: NEOP) with a Buy. PT $9.

Morgan analyst say, "In our view, Lymphoseek could become the market leader in the intra-operative lymphatic mapping (ILM) space based on its clinical utility in breast cancer, melanoma, and head and neck cancer. The agent has demonstrated clear statistical superiority to the existing labeling approach, vital blue dye, in clinical trials. We expect Neoprobe to file for approval of Lymphoseek in the US in 3Q 2011."

For more ratings news on Neoprobe Corp. click here and for the rating history of Neoprobe Corp. click here.

Shares of Neoprobe Corp. closed at $4.66 yesterday.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

New Coverage

Related Entities

Morgan Joseph